168 related articles for article (PubMed ID: 36977496)
21. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y; Li H; Luo D; Jiang J; Liu B; Li G
Int Immunopharmacol; 2023 Sep; 122():110600. PubMed ID: 37423157
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
[TBL] [Abstract][Full Text] [Related]
23. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S; Yıldız K; Acarı C; Dundar HA; Kır M; Ünsal E
Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
[TBL] [Abstract][Full Text] [Related]
24. Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease.
Wu R; Jiang W; Sun Y; Wu L; Di Y; Wang J; Zhong S; Wang W
J Clin Rheumatol; 2023 Apr; 29(3):126-131. PubMed ID: 36730421
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
Chang LS; Lin YJ; Yan JH; Guo MM; Lo MH; Kuo HC
BMC Pediatr; 2020 Aug; 20(1):398. PubMed ID: 32838756
[TBL] [Abstract][Full Text] [Related]
26. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
Zhang H; Zhang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):461-468. PubMed ID: 38802905
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study.
Türkuçar S; Kaya ÜA; Çakmak F; Haşlak F; Demir F; Karabulut E; Makay B; Bilginer Y; Ayaz NA; Sözeri B; Kasapçopur Ö; Karagöz T; Ünal N; Özen S; Ünsal E
Turk J Pediatr; 2023; 65(1):64-72. PubMed ID: 36866986
[TBL] [Abstract][Full Text] [Related]
30. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
31. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.
An HS; Kim GB; Song MK; Lee SY; Kwon HW; Lee JW; Bae EJ
Pediatr Rheumatol Online J; 2021 Jun; 19(1):78. PubMed ID: 34078404
[TBL] [Abstract][Full Text] [Related]
32. Kawasaki disease coronary artery lesions prediction with monocyte-to-high-density lipoprotein ratio.
Yang C; Yang Y; Cao S; Ma Z; Du H; Li J; Dou F; Zhao Y; Li X; Hu X
Pediatr Res; 2023 Jul; 94(1):246-251. PubMed ID: 36446921
[TBL] [Abstract][Full Text] [Related]
33. Predictive potential of age-group cut-off values of N-terminal pro-brain natriuretic peptide in Kawasaki disease.
Hirai S; Nakamura T; Misawa M
Pediatr Int; 2022 Jan; 64(1):e15371. PubMed ID: 36166642
[TBL] [Abstract][Full Text] [Related]
34. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
35. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
Chen YL; Wang JL; Li WQ
Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
Giannouli G; Tzoumaka-Bakoula C; Kopsidas I; Papadogeorgou P; Chrousos GP; Michos A
Pediatr Cardiol; 2013 Aug; 34(6):1476-81. PubMed ID: 23463134
[TBL] [Abstract][Full Text] [Related]
37. Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease.
Chen Y; Yang M; Zhang M; Wang H; Zheng Y; Sun R; Li X
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):866-882. PubMed ID: 38357816
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
39. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
Li G; Wang T; Li J; Chen P; Jia P; Zhao J; Duan Y; Liu D; Xu X; Liu B
Clin Chim Acta; 2020 Aug; 507():264-270. PubMed ID: 32387635
[TBL] [Abstract][Full Text] [Related]
40. The role of red blood cell distribution width in predicting coronary artery lesions in pediatric patients with kawasaki disease.
Cai J; Tang M; Shuai S; Zhang R; Zhang H; Yang Y; Wu M; Liang H; Xing S
Front Cardiovasc Med; 2023; 10():1014890. PubMed ID: 36937943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
